Cost and effectiveness of cardiovascular prevention

Am J Cardiol. 2007 Nov 1;100(9):1492-4; author reply 1494-5. doi: 10.1016/j.amjcard.2007.06.014. Epub 2007 Jul 18.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Cardiovascular Diseases / economics*
  • Cardiovascular Diseases / prevention & control*
  • Cost of Illness
  • Cost-Benefit Analysis
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / economics
  • Mass Screening / economics*
  • Myocardial Infarction / economics
  • Myocardial Infarction / prevention & control
  • Practice Guidelines as Topic
  • Primary Prevention / economics
  • United States

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors